Autoantibodies against type I IFNs in patients with life-threatening COVID-19
생명을 위협하는 COVID-19 환자에서 I형 IFN에 대한 자가항체
Research Article
[키워드] Activation
acute disease
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
adaptive
Affect
affected
age
antiviral immunity
Asymptomatic
auto-Ab
auto-Abs
autoantibodies
autoantibody
autoantibody system
Autoimmune
Autoimmunity
B cell
Beck
binding
can not
candidate gene approach
cause
causes
Clinical course
clinical phenotype
clinical phenotypes
clinical variability
collected
complex
component
components
Concentration
conditions
coronavirus
coronavirus disease
Coronavirus disease 2019
correlated
Course
COVID-19
COVID-19 pandemic
COVID-19 patients
COVID-19 pneumonia
Critical
Critical disease
cytokine
Cytokines
damage
dampen
death
determine
disease
Diseases
downstream
enrichment
enrolment
epidemiological
excess
explain
Genes
genetics
genomics study
had milder phenotype
healthy control
healthy individual
healthy individuals
highest
Human
Hypothesis
identify
IFN
IFN response
IFN-stimulated genes
IFN-α
IFN-α/β
IFN-α2
IFN-β
IFN-γ
IFNAR
IFNs
IgG
IL-17A
IL-6
immune system
Immunity
Immunoglobulin
Immunoglobulin G
immunological
impair
impairing
in healthy individuals
in vitro
Inborn errors
increase in
individual
infected with SARS-CoV-2
Infection
Infectious diseases
interferon
interferon regulatory factor
interferon-γ
interferons
interferons (IFNs)
interleukin
interleukin-6
intrinsic
involved
IRF
ISGs
lack
life-threatening
life-threatening coronavirus disease
likelihood
male
mechanism
men
mild SARS-CoV-2 infection
morbidity
morbidity and mortality
mucocutaneous candidiasis
Mutation
mycobacterial disease
neutralize
Neutralizing
outcomes
pandemic
pathogen
pathogen-induced inflammation
pathway
Patient
patients
patients hospitalized
Perspective
phosphorylated
Plasmapheresis
Pneumonia
Prevent
pSTAT
receptor
receptors
Regulation
respiratory
rising
risk
risk factor
SARS-CoV-2
SARS-COV-2 infection
Science
searched
serum IFN-α level
severe acute respiratory syndrome Coronavirus
severe coronavirus disease
severe COVID-19
Severe COVID-19 pneumonia
shown
silent infection
staphylococcal
susceptible
tested
the patient
this system
TLR
Toll-like receptor
Transcription
Treatment
trials
type 1 interferon
type 1 interferons
type I
Type I IFN
type I IFNs
underlie
undetectable
Vaccine
Viral
viral infections
viral respiratory diseases
while
women
[DOI] 10.1126/science.abd4585 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1126/science.abd4585 PMC 바로가기 [Article Type] Research Article